View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Enfortumab Vedotin 1.25, Bladder Cancer
Protocol-ID: 1733 V1.1 (Mini), ENFVED1,25, Bladder CaIndication(s)
- Bladder Cancer; ICD-10 C67.-
Links
- Enfortumab Vedotin (padcev) [EMA EPAR]
- HIGHLIGHTS OF PRESCRIBING INFORMATION: PADCEVTM (enfortumab vedotin-ejfv) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 23.06.2023